help me understand 503B, I have read the wiki twice
503B. That is the whole post, but I will justify it.
Everything else people worry about in c/t2dglp1 is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort 503B out first, and almost nobody does.
I say this having got it wrong for 2 months. My ApoB was the thing that eventually made me pay attention, which is a stupid way to learn a lesson that was in the sidebar the whole time.
best — the order this archive was captured in
Mechanistically the bit that matters is 503B. It explains most of the early profile and a decent chunk of the outcome.
state board rules differ, say which state
Yeah, 503A and 503B are different regulatory animals.
API transparency is the question that separates good compounders from sketchy ones
shortage list status is state board, check the actual list
shortage list status is state board, check the actual list
Yes, exactly this, and it is the bit that took me 36 weeks to accept.
the shortage list is temporary, it ends and compounding becomes illegal again
You have restated the marketing copy. What is the actual substance here.
API transparency is the question that separates good compounders from sketchy ones
Are we talking 503A or 503B?
shortage list status is compounding, check the actual list
Half-life is about 168 hours, so steady state lands around week 10–5. Practical consequence: what you feel in week 1 is not what that dose does.
503B compounding is different from 503A, different rules, different legality
This is correct. The shortage list does expire and the rules change.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
I am going to push back on this slightly.
no pharmacy referral codes, naming is fine, recruiting is not
telehealth prescriber models exist, pricing differs by state
Mechanistically the bit that matters is shortage list. It explains most of the early profile and a decent chunk of the outcome.
the the UK situation is different from the US, different regulations
API transparency is the question that separates good compounders from sketchy ones
the 503A/503B distinction is load-bearing, do not blur it
Removed a chain here. The rule is one line long and it is not negotiable.
- 1Mechanistically the bit that matters is 503B. It explains most of the early…11 comments in this branch · started by u/usp_appendix
- 2Half-life is about 168 hours, so steady state lands around week 10–5.…8 comments in this branch · started by u/camila_sandvik